News

SBRI: assays for SARS-CoV-2 cellular immune responses

Published on: 03/05/2021

SBRI: assays for SARS-CoV-2 cellular immune responses
Funding
Member News, Funding news

Opportunity status: Open
Funders: Innovate UK, UK Research and Innovation
Funding type: Other
Total fund: £1,500,000
Publication date: 14 April 2021
Opening date: 26 April 2021
Closing date: 26 May 2021 11:00 UK time

See the full opportunity details on the Innovation Funding Service.

This is a Small Business Research Initiative (SBRI) competition funded by UKRI. The competition is part of the COVID-19 National Core Studies (NCS) programme.

The programme’s objective is to address key research questions in support of the UK government’s response to COVID-19.

Eligibility summary

You can lead a project alone or work with other organisations as subcontractors.

Contracts will be awarded to a single legal entity only.

You must:

  • demonstrate experience in assay system development
  • work in the field of cellular immunology
  • include appropriate clinical expertise.

SOURCE: https://www.ukri.org/opportunity/sbri-assays-for-sars-cov-2-cellular-immune-responses/?elqTrackId=D16268D772A707414C038417EA6F19D4&elq=0263abc775ed490d88f1f6257a20c374&elqaid=1712&elqat=1&elqCampaignId=1033

NEWS​

Related News

New Round Tables announced to drive progress on EHDS and health AI

3 Jul 2025

The European Accessibility Act Is Here. Are You Ready?

2 Jul 2025
Why inclusive design is no longer optional – and how Big Motive can help you lead the way.

DTH-Lab Director: The G7 must act now to address the digital health transformation

2 Jul 2025
As digital platforms increasingly shape health systems and information flows, the G7 must lead in setting global standards to ensure safety, equity an...

InnoHSupport Open Calls

1 Jul 2025
Welcome to the InnoHSupport Open Calls!

Transformative Health Instrument Call 2025

1 Jul 2025
Apply to the Transformative Health Instrument (THI) Call 2025 if you are a growing and innovative healthcare start-up working on solutions that have s...

Longitude Prize on ALS

1 Jul 2025
The £7.5 million (~$10 million) Longitude Prize on ALS incentivises the use of AI-based approaches to transform drug discovery for amyotrophic lateral...

Become a member

Join ECHAlliance to amplify your organisation’s message, grow your networks, connect with innovators and collaborate globally.
 
First name *
Last Name *
Email Address *
Country *
Position *
First name *
Last Name *
Email Address *
Country *
Position *